(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ Composite: ARCT) slid 5.79% to $31.57 at 13:28 EST on Thursday, after two sequential sessions in a row of losses. NASDAQ Composite is jumping 0.05% to $14,942.83, after three sequential sessions in a row of gains. This seems, up until now, a somewhat positive trend exchanging session today.
Arcturus Therapeutics’s last close was $32.07, 74.14% below its 52-week high of $124.00.
Volume
Today’s last reported volume for Arcturus Therapeutics is 207482 which is 64.44% below its average volume of 583631.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.12%, a positive 0.68%, and a positive 3.90%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 2.21% (last week), 4.51% (last month), and 3.90% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be overbought (>=80).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $31.57 at 13:28 EST, way under its 52-week high of $124.00 and way higher than its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s value is way below its 50-day moving average of $40.67 and way under its 200-day moving average of $40.29.
More news about Arcturus Therapeutics (ARCT).
